Longitudinal assessment of the dose consistency of botulinum toxin type a (BOTOX®) for cervical dystonia
- 70 Downloads
Botulinum toxin type A (BoNT/A) is the principal therapy for patients with cervical dystonia. Repeated treatments over many years are required in most cases. This retrospective review evaluates the dose of BoNT/A used to treat cervical dystonia and the interval between treatments during a 2-year observation period. Outcomes data were abstracted from the medical records of 172 patients at 3 different sites who had received BoNT/A between January and December 1998. A total of 1059 treatments were assessed. Mean per-treatment doses throughout the 2-year study ranged from 241.80 to 254.07 units. The mean interval between treatments was 108.48 days during the first year of observation and 114.14 days during the second year. These findings indicate that doses of and intervals between BoNT/A treatments for cervical dystonia were consistent throughout 2 years of observation.
Keywordsbotulinum toxin type A cervical dystonia spasmodic torticollis
Unable to display preview. Download preview PDF.
- 6.Naumann M, Yakovleff A, Durif F. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia.J Neurol. 2002;249:57–63.PubMedCrossRefGoogle Scholar
- 15.BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex prescribing information. Allergan, Inc, Irvine, Calif, 2000.Google Scholar
- 20.Hauser RA, Comella C, Brashear A, et al. A randomized, multicenter, double-blind, placebo-controlled study of original Botox (botulinum toxin type A) purified neurotoxin complex for the treatment of cervical dystonia [abstract].Mov Disord. 2000;15(suppl 2):30–31.Google Scholar